126 related articles for article (PubMed ID: 1394437)
21. Effects of immunomodulating treatment on autoimmune sialadenitis in MRL/Mp-lpr/lpr mice.
Jonsson R; Tarkowski A; Bäckman K
Agents Actions; 1988 Dec; 25(3-4):368-74. PubMed ID: 3218611
[TBL] [Abstract][Full Text] [Related]
22. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
Huang FP; Feng GJ; Lindop G; Stott DI; Liew FY
J Exp Med; 1996 Apr; 183(4):1447-59. PubMed ID: 8666903
[TBL] [Abstract][Full Text] [Related]
23. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
Shiraki M; Fujiwara M; Tomura S
Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
[TBL] [Abstract][Full Text] [Related]
24. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
25. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
[TBL] [Abstract][Full Text] [Related]
26. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.
Gyotoku Y; Abdelmoula M; Spertini F; Izui S; Lambert PH
J Immunol; 1987 Jun; 138(11):3785-92. PubMed ID: 3495570
[TBL] [Abstract][Full Text] [Related]
27. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M
Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422
[TBL] [Abstract][Full Text] [Related]
28. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
[TBL] [Abstract][Full Text] [Related]
29. Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: a spontaneous model for human microscopic angiitis.
Harper JM; Thiru S; Lockwood CM; Cooke A
Eur J Immunol; 1998 Jul; 28(7):2217-26. PubMed ID: 9692891
[TBL] [Abstract][Full Text] [Related]
30. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
31. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
Tada Y; Koarada S; Tomiyoshi Y; Morito F; Mitamura M; Haruta Y; Ohta A; Nagasawa K
Clin Immunol; 2006 Aug; 120(2):179-88. PubMed ID: 16616645
[TBL] [Abstract][Full Text] [Related]
32. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Burek CL; Hu Q; Kuppers RC; Lee B; Prendergast RA
Cell Immunol; 1992 May; 141(2):496-507. PubMed ID: 1576659
[TBL] [Abstract][Full Text] [Related]
33. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
[TBL] [Abstract][Full Text] [Related]
34. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
[TBL] [Abstract][Full Text] [Related]
35. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
[TBL] [Abstract][Full Text] [Related]
36. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
Merino R; Shibata T; De Kossodo S; Izui S
Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
[TBL] [Abstract][Full Text] [Related]
37. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
Atkinson C; Qiao F; Song H; Gilkeson GS; Tomlinson S
J Immunol; 2008 Jan; 180(2):1231-8. PubMed ID: 18178863
[TBL] [Abstract][Full Text] [Related]
38. Effects of nutrition on disease and life span. I. Immune responses, cardiovascular pathology, and life span in MRL mice.
Mark DA; Alonso DR; Quimby F; Thaler HT; Kim YT; Fernandes G; Good RA; Weksler ME
Am J Pathol; 1984 Oct; 117(1):110-24. PubMed ID: 6333184
[TBL] [Abstract][Full Text] [Related]
39. Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis.
Yoneda T; Ishimaru N; Arakaki R; Kobayashi M; Izawa T; Moriyama K; Hayashi Y
Endocrinology; 2004 May; 145(5):2384-91. PubMed ID: 14726437
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody.
Jabs DA; Prendergast RA
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2718-22. PubMed ID: 1680111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
